Published on 23 May 2024 on Investing.com
AbbVie finalizes Landos Biopharma acquisition By Investing.com
The acquisition deal was settled at $20.42 per share, along with a non-tradable contingent value...
NYSE.ABBV price evolution
Want to become a better investor?
Start tracking your investments with Statfolio
Sign up for free